Search clinical trials for: Galunisertib
Total 14 results
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedMyelodysplastic SyndromesGermany, Spain, Italy
-
Abramson Cancer Center of the University of PennsylvaniaCompletedADVANCED HEPATOCELLULAR CARCINOMA (HCC)United States
-
Eli Lilly and CompanyAstraZenecaCompletedMetastatic Pancreatic CancerSpain, United States, Korea, Republic of, France, Italy
-
The Netherlands Cancer InstituteEli Lilly and Company; Universitaire Ziekenhuizen KU Leuven; European Organisation... and other collaboratorsWithdrawnGalunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615)Colorectal Cancer MetastaticNetherlands
-
The Netherlands Cancer InstituteAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Not yet recruitingColorectal Cancer Metastatic | Peritoneal CarcinomatosisNetherlands
-
Stony Brook UniversityFDA Office of Orphan Products Development; State University of New YorkCompletedSepsis | Respiratory Distress Syndrome | Respiratory Distress Syndrome, AdultUnited States
-
Eli Lilly and CompanyBristol-Myers SquibbCompletedSolid Tumor | Hepatocellular Carcinoma Recurrent | Non-Small Cell Lung Cancer RecurrentSpain, United States
-
University of OklahomaEli Lilly and CompanyActive, not recruitingCarcinosarcoma, OvarianUnited States
-
Eli Lilly and CompanyCompletedNeoplasms | Neoplasm Metastasis | Pancreatic CancerUnited States, Germany, Spain, Belgium, Italy, France
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Providence Health & ServicesEli Lilly and CompanyActive, not recruiting
-
Sun Yat-sen UniversityNot yet recruiting